Ansofaxine hydrochloride

CAS No. 916918-84-8

Ansofaxine hydrochloride( LY03005 | LPM570065 )

Catalog No. M20130 CAS No. 916918-84-8

Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 113 In Stock
5MG 164 In Stock
10MG 278 In Stock
25MG 509 In Stock
50MG 731 In Stock
100MG 1017 In Stock
500MG 2034 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ansofaxine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).
  • Description
    Ansofaxine (LY03005; LPM570065) is a serotonin-norepinephrine-dopamine reuptake inhibitor (IC50s: 723 763 and 491 nM respectively).(In Vivo):Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
  • In Vitro
    ——
  • In Vivo
    Ansofaxine rapidly penetrates the rat striatum, converts into desvenlafaxine and exhibits larger total exposure compared with the administration of desvenlafaxine. Acute and chronic administration of oral suspension of ansofaxine increases the 5-HT, dopamine and norepinephrine levels more than the relative administration of desvenlafaxine. Unlike desvenlafaxine, acute administration of an intravenous ansofaxine solution does not induce the undesirable 90% decrease in extracellular 5-HT levels. The acute administration of ansofaxine shows a capped increase in extracellular 5-HT levels when combined with WAY-100635. Acute and chronic administration of ansofaxine reduces the immobility time more than the relative administration of desvenlafaxine.
  • Synonyms
    LY03005 | LPM570065
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    serotonin reuptake| dopamine reuptake| norepinephrine reuptake
  • Research Area
    Neurological Disease
  • Indication
    Major depressive disorder

Chemical Information

  • CAS Number
    916918-84-8
  • Formula Weight
    417.97
  • Molecular Formula
    C24H32ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 30 mg/mL (71.77 mM)
  • SMILES
    Cl.CN(C)CC(c1ccc(OC(=O)c2ccc(C)cc2)cc1)C1(O)CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang R et al. The effects of LPM570065 a novel triple reuptake inhibitor on extracellular serotonin dopamineand norepinephrine levels in rats. PLoS One. 2014 Mar 10;9(3):e91775.
molnova catalog
related products
  • Pectolinarin

    Pectolinarin is a Cirsium isolate with anti-inflammatory activity.

  • Sumatriptan succinat...

    Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.

  • SB 737050A

    SB 737050A is a potent, selective 5-HT6 receptor antagonist to prevent relapse intio addiction.